Skip to main content
SpringerLink
Log in

Comment on: cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis

  • Letter
  • Published:
Osteoporosis International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 2
Fig. 3
Fig. 5

References

  1. Jonsson B, Strom O, Eisman JA, Papaioannou A, Siris ES, Tosteson A, Kanis JA (2010) Cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis. Osteoporos Int 22(3):967–982

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Stockholm School of Economics, Box 6501, 11383, Stockholm, SE, Sweden

    B. Jönsson

  2. Geriatrics and Medicine, McMaster University, Main St W, 1280, Hamilton, ON, Canada

    O. Ström, J. A. Eisman, A. Papaioannou, E. S. Siris, A. Tosteson & J. A. Kanis

Authors
  1. B. Jönsson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. O. Ström
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. A. Eisman
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Papaioannou
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E. S. Siris
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Tosteson
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. J. A. Kanis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to B. Jönsson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jönsson, B., Ström, O., Eisman, J.A. et al. Comment on: cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis. Osteoporos Int 23, 2063–2065 (2012). https://doi.org/10.1007/s00198-011-1830-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-011-1830-8

Keywords

Search

Navigation